JP2011518179A5 - - Google Patents

Download PDF

Info

Publication number
JP2011518179A5
JP2011518179A5 JP2011505212A JP2011505212A JP2011518179A5 JP 2011518179 A5 JP2011518179 A5 JP 2011518179A5 JP 2011505212 A JP2011505212 A JP 2011505212A JP 2011505212 A JP2011505212 A JP 2011505212A JP 2011518179 A5 JP2011518179 A5 JP 2011518179A5
Authority
JP
Japan
Prior art keywords
peptide
amino acid
peptide derivative
acid sequence
derivative according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011505212A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011518179A (ja
JP6038452B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2009/040857 external-priority patent/WO2009137256A1/en
Publication of JP2011518179A publication Critical patent/JP2011518179A/ja
Publication of JP2011518179A5 publication Critical patent/JP2011518179A5/ja
Application granted granted Critical
Publication of JP6038452B2 publication Critical patent/JP6038452B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011505212A 2008-04-17 2009-04-16 生物学的に活性なペプチド Expired - Fee Related JP6038452B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US932608P 2008-04-17 2008-04-17
US61/009,326 2008-04-17
US11305508P 2008-11-10 2008-11-10
US61/113,055 2008-11-10
PCT/US2009/040857 WO2009137256A1 (en) 2008-04-17 2009-04-16 Biologically active peptides

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013263345A Division JP5977223B2 (ja) 2008-04-17 2013-12-20 生物学的に活性なペプチド

Publications (3)

Publication Number Publication Date
JP2011518179A JP2011518179A (ja) 2011-06-23
JP2011518179A5 true JP2011518179A5 (OSRAM) 2011-12-22
JP6038452B2 JP6038452B2 (ja) 2016-12-07

Family

ID=40887122

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2011505212A Expired - Fee Related JP6038452B2 (ja) 2008-04-17 2009-04-16 生物学的に活性なペプチド
JP2013263345A Expired - Fee Related JP5977223B2 (ja) 2008-04-17 2013-12-20 生物学的に活性なペプチド
JP2016143368A Pending JP2017019797A (ja) 2008-04-17 2016-07-21 生物学的に活性なペプチド

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2013263345A Expired - Fee Related JP5977223B2 (ja) 2008-04-17 2013-12-20 生物学的に活性なペプチド
JP2016143368A Pending JP2017019797A (ja) 2008-04-17 2016-07-21 生物学的に活性なペプチド

Country Status (19)

Country Link
US (6) US8563688B2 (OSRAM)
EP (2) EP2279200B1 (OSRAM)
JP (3) JP6038452B2 (OSRAM)
KR (2) KR101606248B1 (OSRAM)
CN (2) CN105524163A (OSRAM)
AR (1) AR071478A1 (OSRAM)
AU (1) AU2009244635B2 (OSRAM)
BR (1) BRPI0911203A2 (OSRAM)
CA (1) CA2721694C (OSRAM)
DK (2) DK3115370T3 (OSRAM)
ES (2) ES2739676T3 (OSRAM)
HK (1) HK1223946A1 (OSRAM)
MX (1) MX2010011397A (OSRAM)
NZ (1) NZ588200A (OSRAM)
PL (1) PL2279200T3 (OSRAM)
PT (1) PT2279200T (OSRAM)
SG (2) SG10201809286XA (OSRAM)
TW (2) TWI573806B (OSRAM)
WO (1) WO2009137256A1 (OSRAM)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI573806B (zh) * 2008-04-17 2017-03-11 巴克斯歐塔公司 生物活性胜肽
US20120263701A1 (en) 2009-08-24 2012-10-18 Volker Schellenberger Coagulation factor vii compositions and methods of making and using same
CN103262532B (zh) 2010-07-19 2018-03-09 杜比实验室特许公司 用于经采样复用的图像和视频数据的增强方法
HUE043894T2 (hu) 2011-06-10 2019-09-30 Bioverativ Therapeutics Inc Koagulációt elõsegítõ vegyületek és alkalmazásuk módszerei
NZ628014A (en) 2012-02-15 2016-09-30 Biogen Ma Inc Recombinant factor viii proteins
MX369862B (es) 2012-02-15 2019-11-25 Bioverativ Therapeutics Inc Composiciones del factor viii y metodos para hacerlas y usarlas.
CN105378059B (zh) * 2013-06-11 2018-12-28 Cj第一制糖株式会社 产l-异亮氨酸微生物和使用该微生物生产l-异亮氨酸的方法
EP3033097B1 (en) 2013-08-14 2021-03-10 Bioverativ Therapeutics Inc. Factor viii-xten fusions and uses thereof
WO2015023894A1 (en) 2013-08-14 2015-02-19 Biogen Idec Ma Inc. Recombinant factor viii proteins
EP3065769A4 (en) 2013-11-08 2017-05-31 Biogen MA Inc. Procoagulant fusion compound
US20160039876A1 (en) 2014-03-28 2016-02-11 Claresa Levetan Insulin independence among patients with diabetes utilizing an optimized hamster reg3 gamma peptide
JP6484468B2 (ja) * 2014-06-03 2019-03-13 ＡｖａｎＳｔｒａｔｅ株式会社 ガラス板製造方法およびガラス板製造装置
GB201410507D0 (en) * 2014-06-12 2014-07-30 Univ Bath Drug delivery enhancement agents
CA2994547A1 (en) 2015-08-03 2017-02-09 Bioverativ Therapeutics Inc. Factor ix fusion proteins and methods of making and using same
JP7035033B2 (ja) 2016-09-28 2022-03-14 コーバー、インコーポレイテッド 治療用ＭＯＴＳ－ｃ関連ペプチド
WO2018102743A1 (en) 2016-12-02 2018-06-07 Bioverativ Therapeutics Inc. Methods of treating hemophilic arthropathy using chimeric clotting factors
CA3051862A1 (en) 2017-01-31 2018-08-09 Bioverativ Therapeutics Inc. Factor ix fusion proteins and methods of making and using same
SG11202010767SA (en) 2018-05-18 2020-11-27 Bioverativ Therapeutics Inc Methods of treating hemophilia a

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4447356A (en) * 1981-04-17 1984-05-08 Olivera Baldomero M Conotoxins
IT1190891B (it) 1982-06-24 1988-02-24 Anic Spa Metodo per la sintesi in fase solida di polipeptidi retroinvertiti
US5122614A (en) 1989-04-19 1992-06-16 Enzon, Inc. Active carbonates of polyalkylene oxides for modification of polypeptides
US5093317A (en) * 1989-06-05 1992-03-03 Cephalon, Inc. Treating disorders by application of insulin-like growth factor
JPH0725794B2 (ja) * 1990-03-23 1995-03-22 呉羽化学工業株式会社 新規なペプチド
US5595732A (en) 1991-03-25 1997-01-21 Hoffmann-La Roche Inc. Polyethylene-protein conjugates
US6037452A (en) 1992-04-10 2000-03-14 Alpha Therapeutic Corporation Poly(alkylene oxide)-Factor VIII or Factor IX conjugate
AU673057B2 (en) 1993-02-22 1996-10-24 Abraxis Bioscience, Llc Methods for (in vivo) delivery of biologics and compositionsuseful therefor
US5439686A (en) 1993-02-22 1995-08-08 Vivorx Pharmaceuticals, Inc. Methods for in vivo delivery of substantially water insoluble pharmacologically active agents and compositions useful therefor
EP0805864A1 (en) * 1994-12-30 1997-11-12 Seminis Vegetable Seeds, Inc. Papaya ringspot virus replicase gene
US5532153A (en) * 1995-03-23 1996-07-02 New England Biolabs, Inc. Method for cloning and producing the SacI restriction endonuclease
US7279548B2 (en) * 1996-04-03 2007-10-09 Cytogen Corporation Identification and isolation of novel polypeptides having WW domains and methods of using same
US6197526B1 (en) 1999-01-04 2001-03-06 Dyax Corp. Polypeptides for binding human factor VIII and fragments of human factor VIII
US6624289B1 (en) 1999-06-16 2003-09-23 Saint Louis University Region of factor IXa protease domain that interacts with factor VIIIa and methods therefor
US7109170B2 (en) 1999-06-16 2006-09-19 Saint Louis University Region of factor IXa protease domain that interacts with factor VIIIa and methods therefor
JP2003503426A (ja) 1999-07-02 2003-01-28 ジェネンテック・インコーポレーテッド ＦＶＩＩａアンタゴニスト
AT411997B (de) 1999-09-14 2004-08-26 Baxter Ag Faktor ix/faktor ixa aktivierende antikörper und antikörper-derivate
US20020018778A1 (en) * 1999-12-06 2002-02-14 Caplan Michael J. Passive desensitization
EP1257289A1 (en) * 2000-02-08 2002-11-20 The Penn State Research Foundation Immunotherapy using interleukin 13 receptor subunit alpha 2
WO2002092623A1 (en) * 2001-05-11 2002-11-21 Research Development Foundation INHIBITORS OF RECEPTOR ACTIVATOR OF NF-κB AND USES THEREOF
FR2830865B1 (fr) * 2001-10-17 2004-10-22 Centre Nat Rech Scient Leurres peptidiques pour la preparation de medicaments destines a la prevention ou au traitement des pathologies auto-immunes, ou des troubles lies a l'apparition d'anticorps diriges contre des proteines exogenes
US20060204503A1 (en) * 2005-01-31 2006-09-14 Biogen Idec Ma Inc. Treatment of cancer using antibodies to polypeptides differentially expressed in human lung tumors
WO2007065691A2 (en) * 2005-12-07 2007-06-14 Technische Universität München Small peptidic and peptido-mimetic affinity ligands for factor viii and factor viii-like proteins
EP1981987A2 (en) 2006-01-04 2008-10-22 Do-Coop Technologies Ltd Compositions and methods for enhancing in-vivo uptake of pharmaceutical agents
TWI573806B (zh) * 2008-04-17 2017-03-11 巴克斯歐塔公司 生物活性胜肽

Similar Documents

Publication Publication Date Title
JP2011518179A5 (OSRAM)
EP2717898B1 (en) Pro-coagulant compounds and methods of use thereof
TWI573806B (zh) 生物活性胜肽
RU2008141280A (ru) Агонисты рецептора нейромедина u и их применение
RU2017114414A (ru) НОВЫЕ АНТАГОНИСТЫ α4β7 НА ОСНОВЕ МОНОМЕРНЫХ И ДИМЕРНЫХ ПЕПТИДОВ
JP2002530430A (ja) Ｃ型肝炎ウイルスｎｓ３プロテアーゼ阻害用の医薬組成物
JP2010500298A (ja) 癌のような変更された細胞遊走に関連する障害の治療のための薬理学的活性を有するペプチド
JP2006506942A5 (OSRAM)
EP3862014A1 (en) Treatment of panx1 associated diseases
AU2022222674A9 (en) Glucagon-like peptide-1 receptor antagonists
WO2018156892A1 (en) Peptide inhibitors of transcription factor aggregation
US20200172587A1 (en) Hydrochloride salts of c5a receptor agonist peptides
JP2949129B2 (ja) 胃腸運動刺激活性を有するモチリン類似ポリペプチド
JPH10501003A (ja) 免疫調節作用を有する新規ペプチド
JP2001514659A (ja) ドラスタチン−１５誘導体とタキサンとの併用
ES2282494T3 (es) Analogos de la hormona liberadora de la hormona de crecimiento humana, su preparacion y uso.
JP2008531463A5 (OSRAM)
JP2002507886A (ja) アンギオテンシン誘導体
JP2003500334A (ja) 抗ｈｉｖ作用を有するｒａｎｔｅｓ由来ペプチド
CN107847452A (zh) 应答选择性C5a激动剂EP67的构象稳定类似物
JPWO2016063969A1 (ja) ヘマグルチニン結合ペプチド
TW202415676A (zh) 升糖素樣肽-1受體拮抗劑
US6596692B1 (en) Substance P analogs for the treatment of cancer
EP1337551B1 (en) Substance p analogs for the treatment of cancer
CN116157140A (zh) 具有肾酶促效剂活性的稳定胜肽